proadifen has been researched along with labetalol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| De Natale, G; Pisanti, N; Preziosi, P; Vacca, M | 1 |
2 other study(ies) available for proadifen and labetalol
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Labetalol disposition interferes with fluorimetric dosage of catecholamines: in vitro and in vivo trials with enzymatic inhibitors.
Topics: Animals; Catecholamines; Enzyme Inhibitors; Ethanolamines; Fluorometry; In Vitro Techniques; Labetalol; Male; Microsomes, Liver; Proadifen; Rats | 1980 |